Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Stefano Palomba, Angela Falbo, Annalisa Di Cello, Caterina Materazzo & Fulvio Zullo. (2012) Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecological Endocrinology 28:9, pages 710-721.
Read now
Read now
Heather Hohmann. (2009) Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive. Patient Preference and Adherence 3, pages 205-211.
Read now
Read now
Anna Olsen, Cathy Banwell & Phyll Dance. (2009) Internal or Infernal Devices: Experiences of Contraception Among Australian Women Living With Hepatitis C. Health Care for Women International 30:6, pages 456-474.
Read now
Read now
Olivier Graesslin & Tjeerd Korver. (2008) The contraceptive efficacy of Implanon®: A review of clinical trials and marketing experience. The European Journal of Contraception & Reproductive Health Care 13:sup1, pages 4-12.
Read now
Read now
K. Gezginc, O. Balci, R. Karatayli & M. C. Colakoglu. (2007) Contraceptive efficacy and side effects of Implanon®. The European Journal of Contraception & Reproductive Health Care 12:4, pages 362-365.
Read now
Read now
Beyhan Yildizbas, H. Guler Sahin, Ali Kolusari, Sahin Zeteroglu & Mansur Kamacı. (2007) Side effects and acceptability of Implanon®: A pilot study conducted in eastern Turkey. The European Journal of Contraception & Reproductive Health Care 12:3, pages 248-252.
Read now
Read now
Articles from other publishers (36)
Brooke E Barton, Jeffery A Erickson, Stephanie I Allred, Jenna M Jeffries, Kalli K Stephens, Mark I Hunter, Kirby A Woodall & Wipawee Winuthayanon. (2023) Reversible female contraceptives: historical, current, and future perspectives. Biology of Reproduction.
Crossref
Crossref
Razaz Wali, Abdulkarim M Alghamdi, Samer T Ahmed, Abdulaziz M Gammash, Mohammed M Bukhari, Khozam F Alkhozam & Mouath H Asiri. (2023) Satisfaction With the Use of Subdermal Contraceptive Implant in Women Attending the Specialized Polyclinic Primary Health Care Center in Jeddah City: A Cross-Sectional Study. Cureus.
Crossref
Crossref
Phu Cuong Nguyen, Hoang Van Nguyen, Van Tien Vu, Van Tran Pham, Dang Quyet Tran & Thanh Tung Nguyen. (2023) Assessment of plasma testosterone, estradiol, and progesterone levels in Vietnam female patients with moderate to severe acne vulgaris. F1000Research 11, pages 23.
Crossref
Crossref
Phu Cuong Nguyen, Hoang Van Nguyen, Van Tien Vu, Van Tran Pham, Dang Quyet Tran & Thanh Tung Nguyen. (2022) Assessment of serum testosterone, estradiol, and progesterone levels in female patients with acne vulgaris. F1000Research 11, pages 23.
Crossref
Crossref
Phu Cuong Nguyen, Hoang Van Nguyen, Van Tien Vu, Van Tran Pham, Dang Quyet Tran & Thanh Tung Nguyen. (2022) Assessment of serum hormone levels in female patients with acne vulgaris. F1000Research 11, pages 23.
Crossref
Crossref
Kusum V. Moray, Himanshu Chaurasia, Oshima Sachin & Beena Joshi. (2021) A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant. Reproductive Health 18:1.
Crossref
Crossref
Dalya Thamer Ahmed. (2021) The Prevalence and Side Effect of Nexplanon in Baghdad. Journal of Evolution of Medical and Dental Sciences 10:43, pages 3689-3693.
Crossref
Crossref
Eka Rusdianto Gunardi & Sulaeman Andrianto Susilo. (2021) Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users. Obstetrics and Gynecology International 2021, pages 1-7.
Crossref
Crossref
. (2021) FSRH Guideline (February 2021) Progestogen-only Implant. BMJ Sexual & Reproductive Health 47:Suppl 1, pages 1-62.
Crossref
Crossref
Tsegaw Yehuala, Ergoye Melese, Kassawmar Angaw Bogale & Baye Dagnew. (2020) Determinants of Implanon Discontinuation among Women Who Use Implanon at Bahir Dar Town Health Institutions, Northwest Ethiopia, 2019: A Case-Control Study. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-8.
Crossref
Crossref
Johannes Bitzer. 2020. Obesity and Gynecology. Obesity and Gynecology
67
73
.
Frances H. Ampt, Megan S.C. Lim, Paul A. Agius, Matthew F. Chersich, Griffins Manguro, Caroline M. Gichuki, Mark Stoové, Marleen Temmerman, Walter Jaoko, Margaret Hellard, Peter Gichangi & Stanley Luchters. (2019) Use of long‐acting reversible contraception in a cluster‐random sample of female sex workers in Kenya. International Journal of Gynecology & Obstetrics 146:2, pages 184-191.
Crossref
Crossref
Shimona Prosad, Tivani P Mashamba-Thompson & Elizabeth Ojewole. (2018) Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol. Systematic Reviews 7:1.
Crossref
Crossref
Kim C Dobromilsky, Penny L Allen, Stephen H Raymond & Bhavna Maindiratta. (2016)
A prospective cohort study of early postpartum etonogestrel implant (Implanon
®
) use and its effect on duration of lochia
. Journal of Family Planning and Reproductive Health Care 42:3, pages 187-193.
Crossref
Crossref
Myrto Ashe. 2015. Integrative Therapies for Depression. Integrative Therapies for Depression
251
262
.
Lucía Cea Soriano, Mari-Ann Wallander, Susan Andersson, Anna Filonenko & Luis Alberto García Rodríguez. (2015) The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network. Pharmacoepidemiology and Drug Safety 24:1, pages 52-58.
Crossref
Crossref
Charlene Lam & Andrea L. Zaenglein. (2014) Contraceptive use in acne. Clinics in Dermatology 32:4, pages 502-515.
Crossref
Crossref
Pierre Clerson, Olivier Graesslin, Adam Gater, Fiona Taylor, Anna Filonenko, Ilka Schellschmidt & Kimberly Rosen. (2014) EVAPIL-R Scale: Continuous Development and Validation of a Tool to Assess Patient-Reported Tolerability of Different Contraceptive Methods in Longitudinal Studies. Clinical Therapeutics 36:5, pages 638-647.e3.
Crossref
Crossref
Alice Mark, Sarita Sonalkar & Lynn Borgatta. (2013) One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement. Contraception 88:5, pages 619-623.
Crossref
Crossref
C. Egarter. (2013) Subdermale kontrazeptive Implantate. Gynäkologische Endokrinologie 11:3, pages 175-183.
Crossref
Crossref
E. Anne MacGregor. (2013) Contraception and Headache. Headache: The Journal of Head and Face Pain 53:2, pages 247-276.
Crossref
Crossref
Lauren B. Hartman, Erica Monasterio & Loris Y. Hwang. (2012) Adolescent Contraception: Review and Guidance for Pediatric Clinicians. Current Problems in Pediatric and Adolescent Health Care 42:9, pages 221-263.
Crossref
Crossref
Eve Espey & Tony Ogburn. (2011) Long-Acting Reversible Contraceptives. Obstetrics & Gynecology 117:3, pages 705-719.
Crossref
Crossref
C. Martin, M. Tanguy, F. Aspeele & S. Fanello. (2011) ?valuation de la tol?rance de l?implant contraceptif selon le contexte de prescription (post-IVG ou non)?: ?tude prospective chez 127?patientes. La Revue Sage-Femme 10:1, pages 19-24.
Crossref
Crossref
Michelle Isley. (2010) Implanon: The Subdermal Contraceptive Implant. Journal of Pediatric and Adolescent Gynecology 23:6, pages 364-367.
Crossref
Crossref
C. Martin, M. Tanguy, F. Aspeele & S. Fanello. (2010) Évaluation de la tolérance de l’implant contraceptif selon le contexte de prescription (post-IVG ou non) : étude prospective chez 127 patientes. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39:8, pages 632-636.
Crossref
Crossref
Kirsten I. Black, Sunanda Gupta, Angela Rassi & Ali Kubba. (2010) Why do women experience untimed pregnancies? A review of contraceptive failure rates. Best Practice & Research Clinical Obstetrics & Gynaecology 24:4, pages 443-455.
Crossref
Crossref
Peter Ritzmann. (2010) Langwirkende Gestagen-Kontrazeptiva. pharma-kritik 31:10.
Crossref
Crossref
C. Stanley Chan, Mandy Harting & Ted Rosen. (2009) Systemic and barrier contraceptives for the dermatologist: a review. International Journal of Dermatology 48:8, pages 795-814.
Crossref
Crossref
Zara Haider & Rachel D'Souza. (2009) Non ? contraceptive benefits and risks of contraception. Best Practice & Research Clinical Obstetrics & Gynaecology 23:2, pages 249-262.
Crossref
Crossref
Kristen A. Plastino & Patricia J. Sulak. (2008) New Forms of Contraception. Obstetrics and Gynecology Clinics of North America 35:2, pages 185-197.
Crossref
Crossref
Mary A. Fischer. (2008) Implanon: A New Contraceptive Implant. Journal of Obstetric, Gynecologic & Neonatal Nursing 37:3, pages 361-368.
Crossref
Crossref
HEATHER HOHMANN & MITCHELL D. CREININ. (2007) The Contraceptive Implant. Clinical Obstetrics and Gynecology 50:4, pages 907-917.
Crossref
Crossref
Eric Vidin, Olivier Garbin, Brice Rodriguez, Romain Favre & Karima Bettahar-Lebugle. (2007) Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception 76:1, pages 35-39.
Crossref
Crossref
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:8, pages i-xii.
Crossref
Crossref
Aaron F. Hamlin. (2010) Reframing the Presentation of Contraception Pregnancy Rates: Integrating Long-Term Planning and Dual Methods. SSRN Electronic Journal.
Crossref
Crossref